Industry pledges faster and fairer drug delivery across EU

Policy overhaul could see waiting times reduced for underserved member states, pharma group says

Pharmaceutical companies in Europe have pledged to implement fairer pricing and delivery policies in response to concerns that patients in some EU countries are waiting almost two and a half years for new medicines.

Publishing a strategy paper on 11 April, the European Federal of Pharmaceutical Industries and Associations (Efpia) said new proposals including a commitment to transparent drug pricing across the EU would “reduce inequalities in patient access to medicines across Europe”.